Home LiteratureArticle Details
PMID: 5683580 Published · ppublish English Journal Article

Histology, protein clearances, and response to treatment in the nephrotic syndrome.

British medical journal ·Vol. 4 ·No. 5627 ·1968-11-09 ·Pages 352-6

Cameron JS

Abstract

In a group of 400 nephrotic patients, both adults and children, the histological picture seen on renal biopsy, the selectivity of differential protein clearances, and the response to corticosteroid therapy where applied were studied. The only discernible difference was that of the relative incidence of underlying renal disease; in particular, the much greater incidence of "minimal change" lesions and the near absence of glomerular disease secondary to systemic disorders in children. Highly selective differential protein clearances were strongly associated with response to steroids within eight weeks, and this depended on the relation between this type of protein clearance and the minimal change lesion, which was the only histological appearance associated with complete response to corticosteroid therapy within eight weeks. Neither renal biopsy nor studies of proteinuria allowed prediction of which responding patients would subsequently relapse.Studies of differential protein clearances allow the paediatrician to avoid renal biopsy with safety in nephrotic children aged 1 to 5 years, but cannot distinguish any given renal disease with certainty. Generalized diseases affecting the kidney are usually associated with poorly selective differential protein clearances. Within all groups the most severe changes were usually associated with the least selective differential protein clearances, and vice versa.

MeSH Terms
Adolescent Adult Age Factors Child Child, Preschool Humans Infant Kidney/pathology,physiopathology Kidney Diseases/complications Kidney Function Tests Nephrotic Syndrome/complications,drug therapy,pathology,physiopathology Prednisolone/therapeutic use Prednisone/therapeutic use Proteins/metabolism Proteinuria
Chemicals
Proteins Prednisolone Prednisone
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Cameron J S
References (11)
11 references, click to expand
  1. SELECTIVITY OF PROTEINURIA IN CHILDREN WITH THE NEPHROTIC SYNDROME.
    Lancet. 1965 Feb 27;1(7383):463-5 PMID: 14241888
  2. SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME.
    J Clin Invest. 1964 Dec;43:2332-46 PMID: 14234829
  3. SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.
    J Clin Invest. 1964 Aug;43:1507-17 PMID: 14201535
  4. THE EXCRETION OF ALBUMIN AND GLOBULIN IN NEPHRITIS.
    J Clin Invest. 1927 Jun;4(2):235-51 PMID: 16693756
  5. The clinical significance of glomerular permeability studies.
    Proc R Soc Med. 1966 Jun;59(6):512-5 PMID: 5949428
  6. The nephrotic syndrome. Diagnosis by renal biopsy and biochemical and immunological analyses related to the response to steroid therapy.
    Q J Med. 1960 Apr;29:235-56 PMID: 13801232
  7. Evaluation of clinical methods for detecting proteinuria.
    Lancet. 1967 Sep 2;2(7514):489-92 PMID: 4166409
  8. The simple assessment of selectivity in heavy proteinuria.
    Lancet. 1966 Jul 30;2(7457):242-7 PMID: 4161419
  9. Long-term assessment of steroid therapy in childhood nephrosis.
    Lancet. 1966 Oct 15;2(7468):819-21 PMID: 4162167
  10. Estimation of eight serum proteins by a gel diffusion precipitin technique.
    J Lab Clin Med. 1962 May;59:859-70 PMID: 13915219
  11. Cytotoxic drug therapy in steroid-resistant glomerulonephritis.
    Proc R Soc Med. 1967 Nov 1;60(11 Part 1):1164-8 PMID: 6060717
Article Info
Journal
British medical journal
Abbr.
Br Med J
ISSN
0007-1447
Published
1968-11-09
Pages
352-6
Language
English
Region
England
NLM ID
0372673
PMCID
PMC1912574
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com